| Authors: |
Oh MS; Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA., Garon EB; Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA., Lisberg AE; Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA., Cummings AL; Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA., Barrett A; Medical Affairs, Tempus Labs, Inc., Chicago, IL., Ashok A; Medical Affairs, Tempus Labs, Inc., Chicago, IL., Mauer E; Medical Affairs, Tempus Labs, Inc., Chicago, IL., Yilma B; Medical Affairs, Tempus Labs, Inc., Chicago, IL., Goldman JW; Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA. Electronic address: jwgoldman@mednet.ucla.edu. |
